Worcester HIV Vaccine
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.whvaccine.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Worcester HIV Vaccine
- Target Recruit Count
- 42
- Registration Number
- NCT04927585
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
News
No news found